Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|15|3|251-264

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.15, Iss.3, 2014-03, pp. : 251-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation

By Hassan Moustapha   Andersson Borje S  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 75-87

Future Medicine

Access to resources Recommend Favorite

Intravenous Busulfan: In the Conditioning Treatment of Pediatric Patients Prior to Hematopoietic Stem Cell Transplantation

By Hoy Sheridan M.   Lyseng-Williamson Katherine A.  

Pediatric Drugs, Vol. 9, Iss. 4, 2007-01 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation

By Główka Franciszek K   Romański Michał   Wachowiak Jacek  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1275-1295

Informa Healthcare

Access to resources Recommend Favorite

Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial

By Mohty Mohamad   Malard Florent   Blaise Didier   Milpied Noel   Furst Sabine   Tabrizi Resa   Guillaume Thierry   Vigouroux Stéphane   El-Cheikh Jean   Delaunay Jacques   Le Gouill Steven   Moreau Philippe   Labopin Myriam   Chevallier Patrice  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 562-569

Blackwell Publishing

Access to resources Recommend Favorite

Busulfan in hematopoietic stem cell transplant setting

By McCune Jeannine S   Holmberg Leona A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 957-969

Informa Healthcare

Access to resources Recommend Favorite